Holly Drugs Private Limited - Company Profile

It is a pharma private limited company based in Chandigarh, Chandigarh, India, established in 2007.
2007 Chandigarh, Chandigarh, India Active
Last Updated:
Access Report
About Holly Drugs Private Limited

Holly Drugs Private Limited, a active private limited company, was established on 18 July 2007 in Chandigarh, Chandigarh, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24232CH2007PTC030879. Registered under ROC Roc Chandigarh. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Its leadership includes Manju Batra (Additional Director), Deepak Batra (Director). Past directors included Sahil Batra, Sandeep Batra. It holds ₹6.50 M open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Sco 392, 2Nd Floor Sector 37D, Chandigarh, Chandigarh, 160036.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232CH2007PTC030879

  • Registration Number

    030879

  • Incorporation Date

    18 July 2007

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Chandigarh

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 18 Year, 7 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 6.50 M
  • Revenue Growth **** 27.77%
  • Profit Growth **** -25.78%
  • Ebitda **** 9.51%
  • Net Worth 8.44%
  • Total Assets **** 7.95%
Company report

Holly Drugs Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Holly Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Holly Drugs Private Limited?
Current Directors
Name Designation Appointment Date Status
Manju Batra Additional Director 07 Oct 2024 Current
Deepak Batra Director 18 Jul 2007 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 31 Dec 2020 Past
Pramod Abcsdd Director 31 Mar 2018 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Holly Drugs.

Holly Drugs Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 27.77% increase. The company also saw a substantial fall in profitability, with a 25.78% decrease in profit. The company's net worth moved up by a moderate rise of 8.44%.

Holly Drugs revenue growth over time
Holly Drugs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 27.77%
*******
*******
*******
*******
Revenue from Operations
*******
 27.84%
*******
*******
*******
*******
Total Assets
*******
 7.95%
*******
*******
*******
*******
Profit or Loss
*******
 -25.78%
*******
*******
*******
*******
Net Worth
*******
 8.44%
*******
*******
*******
*******
EBITDA
*******
 9.51%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Holly Drugs?

In 2022, Holly Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹6,500,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Indian Bank : 0.40 Cr
  • State Of India : 0.25 Cr
Latest Charge Details
Date Lender Amount Status
24 Aug 2013 Indian Bank ₹4.00 M Open
26 Nov 2007 State Of India ₹2.50 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Holly Drugs?

Unlock and access historical data on people associated with Holly Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Holly Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Holly Drugs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Holly Drugs
Recent Activity within the Organization
  • Annual General Meeting

    Holly Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Holly Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chandigarh. was recorded as a recent event.

  • Director Appointment

    Progress on Manju Batra was appointed as a Additional Director was appointed as a Additional Director on 07 Oct 2024 & has been associated with this company since 1 year 4 months . was documented.

  • Charges

    Progress on A charge with Indian Bank amounted to Rs. 4.00 M with Charge ID 10454303 was registered on 24 Aug 2013. was documented.

  • Charges

    Progress on A charge with State Of India amounted to Rs. 2.50 M with Charge ID 10084974 was registered on 26 Nov 2007. was documented.

  • Director Appointment

    Progress on Deepak Batra was appointed as a Director was appointed as a Director on 18 Jul 2007 & has been associated with this company since 18 years 7 months . was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Holly Drugs Private Limited?

The CIN of Holly Drugs Private Limited is U24232CH2007PTC030879.

Where is Holly Drugs Private Limited headquartered?

Holly Drugs Private Limited is headquartered at Sco 392, 2Nd Floor Sector 37D, Chandigarh, Chandigarh, 160036.

When was Holly Drugs Private Limited incorporated?

Holly Drugs Private Limited was incorporated on 18 July 2007.

Who are the current directors of Holly Drugs Private Limited?

The current directors of Holly Drugs Private Limited are

What is the primary industry of Holly Drugs Private Limited?

The primary industry of Holly Drugs Private Limited is Trade.

Is Holly Drugs Private Limited a listed company?

Holly Drugs Private Limited is unlisted.

What is the capital structure of Holly Drugs Private Limited?

The authorized capital of Holly Drugs Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Holly Drugs Private Limited?

The compliance status of Holly Drugs Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available